Procter & Gamble CO 8-K filings

Procter & Gamble's Board of Directors has declared a quarterly dividend of $1.0065 per share, continuing its long history of dividend payments.

Procter & Gamble successfully completed a $1 billion debt offering, issuing notes due in 2029 and 2034.

Procter & Gamble reported a 2% organic sales growth and a 5% increase in core earnings per share for the first quarter of fiscal year 2025, allowing the company to maintain its full-year guidance.

Procter & Gamble's first quarter fiscal year 2025 results show a slight decrease in net sales but an increase in organic sales, with diluted EPS down due to restructuring charges, while core EPS increased.

Procter & Gamble's 2024 Annual Meeting of Shareholders saw the election of directors, ratification of the accounting firm, and approval of executive compensation, while a pay gap reporting proposal was rejected.

Procter & Gamble declared a quarterly dividend of $1.0065 per share and announced the election of all 14 director nominees at its annual meeting.

Procter & Gamble reported strong fiscal year 2024 results, with 4% organic sales growth and 12% core EPS growth, and provided guidance for continued growth in fiscal year 2025.

Procter & Gamble announced its fourth quarter and fiscal year 2024 results, showing a mixed performance in the quarter but a strong overall fiscal year.

Procter & Gamble's Board of Directors has declared a quarterly dividend of $1.0065 per share, continuing its long-standing tradition of returning cash to shareholders.

Procter & Gamble successfully closed a public offering of $1.5 billion in debt securities, split between notes due in 2028 and 2034.

Procter & Gamble reported strong third-quarter fiscal year 2024 results, highlighted by a 3% organic sales growth and a significant increase in currency-neutral core EPS.

Procter & Gamble reported a 1% increase in net sales and an 11% increase in diluted EPS for the third quarter of fiscal year 2024, while also raising its full-year EPS growth guidance.

Angela F. Braly has announced her retirement from the Procter & Gamble Board of Directors, effective June 11, 2024, to focus on other activities.

Procter & Gamble's Board of Directors has declared a 7% increase in the quarterly dividend, continuing a 68-year streak of dividend growth.

Procter & Gamble successfully closed a public offering of $1.35 billion in debt notes, split between two tranches maturing in 2029 and 2034.

Procter & Gamble reported its second quarter results, showcasing growth in organic sales and core earnings per share, while also detailing a significant non-cash impairment charge.

Procter & Gamble's second quarter fiscal year 2024 saw a 3% increase in net sales and a 4% rise in organic sales, but diluted EPS decreased by 12% due to a non-cash impairment charge.